Investigación / Grupos de investigación

Grupo  3

Enfermedades Sistémicas de Base Autoinmune

Publicaciones (396)

  • Riancho-Zarrabeitia, L; Martinez-Taboada, V; Rua-Figueroa, I; Alonso, F; Galindo-Izquierdo, M; Ovalles, J; Olive-Marques, A; Vazquez, NM; Calvo-Alen, J; Menor-Almagro, R; Tomero-Muriel, E; Uriarte-Isacelaya, E; Botenau, A; Andres, M; Freire-Gonzalez, M; Soler, GS; Ruiz-Lucea, E; Ibanez-Barcelo, M; Castellvi, I; Galisteo, C; Vila, VQ; Raya, E; Narvaez, J; Exposito, L; Hernandez-Beriain, JA; Horcada, L; Aurrecoechea, E; Pego-Reigosa, JM.

    Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 39(3): 555-563 Nº de citas: 2

  • Cid, LAT; Soleto, KCY; Montoro-Alvarez, M; Tenorio, CS; Silva-Riveiro, A; Lopez-Ceron, A; Alfaro, AMA; Motta, LRC; Benavente, BS; Martinez-Barrio, J; Ovalles-Bonilla, JG; Fernandez, CMG; Saez, IM; Nieto-Gonzalez, JC.

    Clinical impact of nailfold capillaroscopy in daily clinical practice

    Reumatologia Clinica. 2021; 17(5): 258-262 Nº de citas: 2 [doi:10.1016/j.reuma.2019.07.008]

  • Collada, JM; Macia-Villa, C; Plasencia, C; Alvaro-Gracia, JM; de Miguel, E.

    Doppler enthesitis: a potential useful outcome in the assessment of axial spondyloarthritis and psoriatic arthritis

    CLINICAL RHEUMATOLOGY. 2021; 40(5): 2013-2020 Nº de citas: 11 [doi:10.1007/s10067-020-05450-4]

  • Alegre-Sancho, JJ; Juanola, X; Rodriguez-Heredia, JM; Manero, J; Villa-Blanco, I; Laiz, A; Arteaga, MJ; Cea-Calvo, L; Gonzalez, CM.

    Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis A retrospective study

    MEDICINE. 2021; 100(13): Nº de citas: 8 [doi:10.1097/MD.0000000000025223]

  • Frutos, AR; Holgado, S; Berge, AS; Casas, I; Olive, A; Lopez-Longo, FJ; Calvo-Alen, J; Galindo, M; Fernandez-Nebro, A; Pego-Reigosa, JM; Rua-Figueroa, I; RELESSER Grp.

    Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)

    RHEUMATOLOGY. 2021; 60(4): 1793-1803 Nº de citas: 34 [doi:10.1093/rheumatology/keaa477]

  • Nieto, JC; Arajol, C; Carmona, L; Marras, C; Cea-Calvo, L.

    Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: a systematic review

    IMMUNOTHERAPY. 2021; 13(5): 433-458 Nº de citas: 5 [doi:10.2217/imt-2021-0011]

  • Alvaro-Gracia, JM; Garcia-Llorente, JF; Valderrama, M; Gomez, S; Montoro, M.

    Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review

    Rheumatology and Therapy. 2021; 8(1): 17-40 Nº de citas: 27 [doi:10.1007/s40744-020-00258-9]

  • Collada, JM; Castrejon, I; Perez, M; Nieto-Gonzalez, JC; Gonzalez, T; Rivera, J; Gonzalez, C; Alvaro-Gracia, JM.

    Clinical impact of musculoskeletal ultrasound on rheumatoid arthritis in routine care

    International Journal of Rheumatic Diseases. 2021; 24(3): 341-346 Nº de citas: 4 [doi:10.1111/1756-185X.14040]

  • Masmitja, JG; Fernandez, CMG; Castro, SG; Laserna, FJR.

    Efficacy of Tofacitinib in the Treatment of Psoriatic Arthritis: A Systematic Review

    ADVANCES IN THERAPY. 2021; 38(2): 868-884 Nº de citas: 10 [doi:10.1007/s12325-020-01585-7]

  • Fernández Castro M; López-Pintor RM; Serrano J; Ramírez L; Sanz M; Andreu JL; Muñoz Fernández S.

    Protocolised odontological assessment of patients with primary Sjögren's syndrome.

    Reumatologia Clinica. 2021; 17(1): 25-31 Nº de citas: 7 [doi:10.1016/j.reuma.2018.12.005]

  • Rivera, J; Castrejon, I; Vallejo-Slocker, L; Offenbacher, M; Molina-Collada, J; Trives, L; Lopez, K; Caballero, L; Hirsch, JK; Toussaint, L; Nieto, JC; Alvaro-Gracia, JM; Vallejo, MA.

    Clinical impact of confinement due to the COVID-19 pandemic on patients with fibromyalgia: a cohort study

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021; 39(3): 78-81 Nº de citas: 2

  • Collada, JM; Trives, L; Castrejon, I.

    The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases

    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS. 2021; 13: 191-200 Nº de citas: 3 [doi:10.2147/OARRR.S276980]

  • Morla, RM; Li, TF; Castrejon, I; Luta, G; Pincus, T.

    Multidimensional Health Assessment Questionnaire as an Effective Tool to Screen for Depression in Routine Rheumatology Care

    ARTHRITIS CARE & RESEARCH. 2021; 73(1): 120-129 Nº de citas: 12 [doi:10.1002/acr.24467]

  • Pablos, JL; Galindo, M; Carmona, L; Lled, A; Retuerto, M; Blanco, R; Gonzalez-Gay, MA; Martinez-Lopez, D; Castrejon, I; Alvaro-Gracia, JM; Fernandez, DF; Mera-Varela, A; Manrique-Arija, S; Vazquez, NM; Fernandez-Nebro, A.

    Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

    ANNALS OF THE RHEUMATIC DISEASES. 2020; 79(12): 1544-1549 Nº de citas: 193 [doi:10.1136/annrheumdis-2020-218296]

  • de Toro, J; Gonzalez, CM; Cea-Calvo, L; Arteaga, MJ; Fernandez, S; Carmona, L; Oton, T.

    Patients' perceptions on shared decision making during prescription of subcutaneous biological drug treatments for inflammatory arthritis: The RHEU-LIFE survey

    Musculoskeletal care. 2020; 18(4): 568-574 Nº de citas: 5 [doi:10.1002/msc.1499]

  • Burmester, GR; Alvaro-Gracia, JM; Betteridge, N; Alen, JC; Combe, B; Durez, P; Fautrel, B; Ferreira, RJO; Gabay, C; Iagnocco, A; Montecucco, C; Ostergaard, M; Ramiro, S; Rubbert-Roth, A; Stamm, T; Szekanecz, Z; Taylor, PC; van de Laar, M.

    Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2020; 38(6): 1056-1067 Nº de citas: 3

  • Manzano, EM; Fernandez-Bello, I; Sanz, RJ; Marhuenda, AR; Lopez-Longo, FJ; Acuna, P; Roman, MTA; Yuste, VJ; Butta, NV.

    Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies

    Journal of Clinical Medicine. 2020; 9(10): Nº de citas: 9 [doi:10.3390/jcm9103297]

  • Arora, S; Isenberg, DA; Castrejon, I.

    Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage

    ARTHRITIS CARE & RESEARCH. 2020; 72: 27-46 Nº de citas: 45 [doi:10.1002/acr.24221]